Introduction {#sec1-1}
============

Retinoblastoma (RB) is the most common intraocular malignancy in childhood and infancy, and 90% of cases are diagnosed before the age of 5 years.\[[@ref1][@ref2][@ref3]\] Since RB is rare in adults, it is not usual to be considered in the differential diagnosis of an intraocular mass in adults.\[[@ref4]\] Search of published peer-reviewed literature showed 26 reported cases of retinoblastoma presenting in adult age,\[[@ref4][@ref5][@ref6][@ref7][@ref8]\] all of which were managed by enucleation \[[Table 1](#T1){ref-type="table"}\]. Herein we present a case of intraocular retinoblastoma in adult patient that was resistant to both chemotherapy and plaque radiation therapy and ended with enucleation.

###### 

Reported cases of retinoblastoma in adults

![](OJO-7-138-g001)

Case Report {#sec1-2}
===========

A 23-year-old Jordanian male patient, medically free, presented with gradual painless visual loss in the right eye associated with floaters for one month prior to presentation. His best corrected visual acuity (BCVA) was 20/400 in the right eye and 20/20 in the left eye. Slit lamp examination of the anterior segment was within normal limit and intraocular pressure was 16 mmHg in the right eye and 15 mmHg in the left eye. Fundus examination showed right inferotemporal white opaque retinal tumor associated with large feeding vessel, vitreous seeds within 3.0 mm from tumor margin, and an epiretinal membrane (ERM) at the temporal part of macula \[[Figure 1](#F1){ref-type="fig"}\]. Left fundus exam was normal. B-scan ultrasonography showed solitary solid intraocular mass with central calcification (thickness = 3.5 mm) with no optic nerve invasion. Similarly, computed tomography (CT) revealed an inferior solid mass (3.5 × 9.5 × 3.5 mm) with intratumoral calcifications, located 6.0 mm from the optic disc with no signs of extra ocular extension \[[Figure 1](#F1){ref-type="fig"}\]. According to the clinical features, diagnosis of unilateral intra-ocular retinoblastoma; international intraocular retinoblastoma (IIRC) group C was established, and the patient was managed accordingly by six cycles (four weeks apart) of carboplatin 500 mg/m^2^ on day one, vincristine 1.50 mg/m^2^ on day one, and etopside 150 mg/m^2^ on days one and two. Consolidating laser therapy (810 laser therapy) was applied after the second cycle. Post chemotherapy, the patient was followed with regular exam every four weeks and was treated with 810 laser therapy for the residual tumor as needed. Seven months post chemotherapy, plaque radiation therapy (Iodine^125^) was applied for tumor progression associated with adjacent vitreous seeds \[[Figure 2](#F2){ref-type="fig"}\]. On follow up, the tumor was inactive but was associated with persistent retinal detachment and ERM. The tumor did not show any signs of growth over the 12-month period post plaque therapy; therefore, retinal detachment (RD) was fixed by pars plana vitrectomy (PPV). Intraoperatively, RD was persistent tractional RD with epiretinal membrane dragging over calcified tumor. RD was repaired by three port PPV and membrane peeling (no drainage) then filled with silicon oil, which was removed 6 months later. Cytopathologic examination of the fluid aspirated during the vitrectomy was negative for malignant cells. Four months post silicon oil removal, the retina was flat but the patient required cataract surgery. Twelve months after PPV, BCVA was counting finger closely with very hazy fundus view. B-scan showed new dome-shaped tumor suggestive of recurrence \[[Figure 2](#F2){ref-type="fig"}\]; therefore enucleation was done. Histopathology of the enucleated eye showed differentiated retinoblastoma, displaying Homer-Wright rosettes and Flexner-Wintersteiner rosettes with no choroidal or optic nerve invasion with no signs of previous retinoma \[[Figure 2](#F2){ref-type="fig"}\].

![Fundus photos of the right eye with retinoblastoma. Poor vision was secondary to the epiretinal membrane (ERM) in the macula (a), due to traction caused by white opaque retinal tumor inferior to the macula (b). The tumor was associated with seeds in the vitreous cavity (c), and had calcifications shown as hyperdensity on computed tomography (CT scan) (d)](OJO-7-138-g002){#F1}

![Tumor features after treatment. The tumor looks fibrotic with no activity 12 months after radioactive iodine125 plaque therapy (a), as well as 9 months after pars plana vitrectomy (PPV) (b). More than 12 months after PPV, B-scan showed new tumor growth (c). Histopathology study after enucleation showed well-differentiated retinoblastoma, displaying Homer-Wright rosettes and Flexner-Wintersteiner rosettes](OJO-7-138-g003){#F2}

Discussion {#sec1-3}
==========

The differential diagnosis of amelanotic intraocular tumor in adults includes amelanotic melanoma, metastasis, hemangioma, lymphoma, leukemia, endophthalmitis, panophthalmitis, and inflammatory diseases of retina as well as retinoma and retinoblastoma.\[[@ref9]\] Retinoblastoma is extremely rare in adults, and more than 90% of cases are diagnosed before the age of 5 years,\[[@ref2]\] making diagnosis of retinoblastoma in adults challenging.

Large opaque white tumors with vitreous seeds can be easily identified as retinoblastoma mainly when associated with calcifications detected by ultrasound and/or CT scan and fluorescein angiography finding of diffuse tumor hyperfluorescence and dilated retinal feeder vessels,\[[@ref10]\] but small solitary lesions may be difficult to diagnose clinically. Calcification, which is a characteristic of retinoblastoma in children, is less common in adult-onset retinoblastoma.\[[@ref11]\]

Retinoma is a benign retinal tumor that is characterized by translucent, grey elevated mass and is frequently associated with cottage cheese calcification and retinal pigment epithelium hyperplasia.\[[@ref12][@ref13][@ref14]\] It carries RB1 gene mutation causing genome instability making it premalignant lesion\[[@ref12][@ref15]\] that requires close observation due to the risk of malignant transformation to retinoblastoma, and genetic testing and counseling is needed if available. Retinoma was observed in 1.8-15.6% of patients with retinoblastoma.\[[@ref12][@ref13][@ref14][@ref15][@ref16]\]

Our patient had ophthalmic features that are more consistent with RB than retinoma and include opaque white color of the tumor, absence of both retinal pigment epithelium hyperplasia and chorioretinal atrophy, diffuse hyperfluorescence in fluorescein angiography, and responsiveness to radiation therapy because unlike RB, retinoma does not change with radiation therapy.\[[@ref17]\] There is no documented normal fundus exam for our patient. Therefore, it was a possible theory that our patient had pre-existing retinoma that transformed to retinoblastoma due to accumulation of oncogenic mutations,\[[@ref18]\] but the pathology did not show any signs suggestive of previous retinoma in our patient. Of interest, 10 out of the 26 previously reported cases of retinoblastoma in adults were associated with retinoma \[[Table 1](#T1){ref-type="table"}\].

Even the tumor in our case was initially responsive to chemotherapy with focal therapy; residual tumor could not be eliminated without radiation therapy (Iodine^125^ Radiaoactive Plaque). The tumor was very resistant even to radiation therapy and recurred after more than one year of stability, and therefore, enucleation could not be avoided.

This report highlights the fact that the presence of an amelanotic mass lesion in the fundus of an adult should raise the suspicion of retinoblastoma. Retinoblastoma in adults may be more resistant to therapy than retinoblastoma in children, and enucleation is recommended mainly if the other eye had good vision.
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